Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
34 min
-
37 min
2. Diabetes through the ages- Dr. Michael Stephen Hall
-
35 min
3. Evolution of diagnostic criteria for diabetes- Prof. Mayer Davidson
-
40 min
4. Diagnosis and screening of diabetes- Prof. Jonathan Shaw
-
53 min
5. The treatment of type 1 diabetes in children and youth- Prof. Francine Kaufman
-
37 min
6. What is new in type 1 diabetes?- Prof. Åke Lernmark
-
33 min
7. Autoimmune diabetes in adults: current evidence and controversies- Prof. Richard David Leslie
-
52 min
8. Type 2 diabetes- Prof. Edward Boyko
-
27 min
9. Inflammation in type 2 diabetes and associated disease- Prof. Marc Y. Donath
-
29 min
10. Pre-gestational diabetes and pregnancy- Prof. Jeremy J. N. Oats
-
37 min
11. Understanding and managing gestational diabetes- Prof. Jeremy J. N. Oats
-
29 min
12. Gene-environment interactions in complex disease- Prof. Paul Franks
-
42 min
13. Diabetes and heart disease- Prof. Trevor J. Orchard
-
46 min
14. The eye and diabetes- Prof. Tien Wong
-
61 min
15. The metabolic syndrome- Prof. Jean Pierre Després
-
44 min
16. Physical activity, sedentary behavior and diabetes- Prof. David Dunstan
-
72 min
17. Cardiovascular prevention in type 2 diabetes- Prof. Eberhardt Standl
-
48 min
18. Economic and social cost of diabetes- Dr. Ping Zhang
-
32 min
19. Diabetes biomarkers- Prof. Naveed Sattar
-
44 min
20. Type 1 diabetes: control and complications trials- Prof. John Petrie
- Archived Lectures *These may not cover the latest advances in the field
-
31 min
21. Latent autoimmune diabetes in adults- Prof. Richard David Leslie
-
25 min
22. Inflammation and type 2 diabetes- Prof. Marc Y. Donath
-
41 min
23. What is new in type 1 diabetes?- Prof. Åke Lernmark
-
46 min
24. Diabetes through the ages- Dr. Michael Stephen Hall
Printable Handouts
Navigable Slide Index
- Introduction
- Funding disclosure
- What is diabetes?
- Defining diagnostic thresholds
- Basis for diabetes cut-points
- Basis of diagnostic criteria for diabetes
- Limitations of bimodality
- Identifying a glucose threshold
- Diabetes complications
- Relative risk of CVD mortality by 2h glucose
- Glucose is not a significant predictor of CVD
- Retinopathy
- Retinopathy - range of FPG thresholds
- Prevalence of retinopathy - FPG (1)
- Prevalence of retinopathy - HbA1c (2)
- Limitations of associations with complications
- HbA1c for the diagnosis of diabetes
- Strengths for HbA1c as a diagnostic tool
- Problems for HbA1c in diagnosing diabetes
- The sensitivity of HbA1c and FPG
- Differences in prevalence and lack of ‘sensitivity’
- Laboratory challenges with glucose and HbA1c
- Analytical issues - glucose
- Fall in blood glucose concentration
- Day-to-day variability
- Pre-analytical issues
- When the diagnostic test is misleading
- Choices of diagnostic tools
- Problems with glucose and HbA1c
- Comparing set of limitations in glucose & HbA1c
- Prevalence of retinopathy - FPG (2)
- Prevalence of retinopathy - HbA1c (2)
- Prevalence of diabetes-specific retinopathy
- Comparing old data with current clinical practice
- HbA1c and glucose are similar for retinopathy
- HbA1c is a valid choice for diabetes diagnosis
- Screening for diabetes
- Screening for asymptomatic type 2 diabetes
- Risk factors for type 2 diabetes and pre-diabetes
- Risk assessment forms for type 2 diabetes
- Australian risk assessment form for diabetes
- Risk assessment by age and gender
- Risk assessment by ethnicity and origin
- Risk assessment by glycemia and family history
- Risk assessment by blood pressure and smoking
- Risk assessment by diet and physical activity
- Risk assessment by waist measurement
- Scoring summation
- Summary
Topics Covered
- Define glucose levels for diabetes diagnosis
- Retinopathy and glycaemia
- Limitations of glucose measurement
- Limitations of HbA1c measurement
- Screening for diabetes with questionnaires
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Shaw, J. (2013, May 22). Diagnosis and screening of diabetes [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 1, 2024, from https://doi.org/10.69645/JPXJ6661.Export Citation (RIS)
Publication History
Financial Disclosures
- Professor Jonathan Shaw has received funding for consultancies and lectures from:Astra Zeneca; Sanofi; Novo Nordisk; MSD; Eli Lilly; Abbott; Mylan; Boehringer Ingelheim
Diagnosis and screening of diabetes
Published on May 22, 2013
40 min
